Top Picks For 2023: Esperion
January 02, 2023 at 15:59 PM EST
Esperion is a de-risked biotech company in the cardiovascular sector with its lead drug, bempedoic acid, already FDA approved to reduce LDL cholesterol. Let's take a closer look at why it's a top pick for 2023.
